Home/Pipeline/Exenatide Depot

Exenatide Depot

Type‑2 Diabetes Mellitus

PreclinicalActive

Key Facts

Indication
Type‑2 Diabetes Mellitus
Phase
Preclinical
Status
Active
Company

About Nanox Release Technology

Nanox creates nanocarrier formulations to enhance delivery of oncology and infectious disease drugs.

View full company profile